Last Call for canSERV Third Open Call Funding
One document
more
Stories about Krebs
- Language:
- Media:
- Period:
- Period:Total
Launch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"
One documentmoreLaunch of canSERV Call for Service Provision, "Training the Next Generation of Cancer Researchers"
One documentmore- 2
Record financing rounds at the Munich biotech hub
One documentmore canSERV relaunches Open Call for Service Provision
One documentmorecanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open
2 DocumentsmorePress release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
One documentmorePress release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...
One documentmorecanSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore LAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision
One documentmore- 3
canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research
One documentmore Leipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
One documentmoreStrengthening the Direct Sales and Service System for Business Expansion in Italy
One documentmore- 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
One documentmore canSERV Releases Open Call for Transnational Service Provision
One documentmoreFree Access to Cancer Research Services - canSERV 1st Call for Proposals
One documentmore- 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
One documentmore - 2
Lindis Biotech develops immunotherapy against bladder cancer
One documentmore - 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
One documentmore The development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB
One documentmore
1